MENU
+Compare
KNTE
Stock ticker: NASDAQ
AS OF
Apr 1 closing price
Price
$2.66
Change
-$0.00 (-0.00%)
Capitalization
125.62M

KNTE stock forecast, quote, news & analysis

Kinnate Biopharma Inc is a clinical-stage precision oncology company focused on the discovery, design, and development of small molecule kinase inhibitors for difficult-to-treat, genomically defined cancers... Show more

A.I.Advisor
published price charts
Interact to see
Advertisement
View a ticker or compare two or three
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
103 Montgomery Street
Phone
+1 858 299-4699
Employees
84
Web
https://www.kinnate.com